The FDA granted de novo approval for a neuromodulation device to treat symptoms associated with post-traumatic stress disorder (PTSD), maker Neurovalens announced Tuesday. The wearable, non-invasive ...
Post-traumatic stress disorder (PTSD) remains one of psychiatry’s most challenging disorders, common, disabling, and biologically complex. Despite decades of research, only sertraline and paroxetine ...
Pain emerges from a complex interplay of peripheral transduction, spinal integration and supraspinal modulation. At the periphery, specialised nociceptors convert thermal, mechanical or chemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results